Search research articles
Contact Us
Filters
Showing results (61-70 of 173) with videos related to
Page
of 18
Sort By:
Cancer Chemotherapy and Pharmacology
|
October 4, 2007
Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines
Nasredine Aissat, Christophe Le Tourneau, Aïda Ghoul, et al.
Oncotarget
|
January 8, 2014
Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas
Cindy Neuzillet, Armand de Gramont, Annemilaï Tijeras-Raballand, et al.
Neuro-Oncology
|
July 12, 2007
Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma
Sophie de Boüard, Paulette Herlin, James G Christensen, et al.
Seminars in Oncology
|
August 8, 2006
Preclinical and clinical development of novel agents that target the protein kinase C family
Maria Serova, Aïda Ghoul, Karim A Benhadji, et al.
Oral Oncology
|
November 7, 2017
Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data
Petr Szturz, Marie Budíková, Jan B Vermorken, et al.
Targeted Oncology
|
August 28, 2012
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies
Annemilaï Tijeras-Raballand, Cindy Neuzillet, Anne Couvelard, et al.
Head & Neck
|
March 8, 2013
Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma
Sébastien Albert, Maria Eugenia Riveiro, Caroline Halimi, et al.
European Journal of Medicinal Chemistry
|
May 20, 2014
Benzofuran derivatives as anticancer inhibitors of mTOR signaling
Christophe Salomé, Nigel Ribeiro, Thierry Chavagnan, et al.
Cancer Treatment Reviews
|
August 20, 2013
Unraveling galectin-1 as a novel therapeutic target for cancer
Lucile Astorgues-Xerri, Maria E Riveiro, Annemilaï Tijeras-Raballand, et al.
European Journal of Medicinal Chemistry
|
January 22, 2014
Benzofuran derivatives as a novel class of inhibitors of mTOR signaling
Christophe Salomé, Vanessa Narbonne, Nigel Ribeiro, et al.
Page
of 18
Search research articles
Search
Showing results (61-70 of 173) with videos related to
Sort By:
Page
of 18
Cancer Chemotherapy and Pharmacology
|
October 4, 2007
Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines
Nasredine Aissat, Christophe Le Tourneau, Aïda Ghoul, et al.
Oncotarget
|
January 8, 2014
Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas
Cindy Neuzillet, Armand de Gramont, Annemilaï Tijeras-Raballand, et al.
Neuro-Oncology
|
July 12, 2007
Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma
Sophie de Boüard, Paulette Herlin, James G Christensen, et al.
Seminars in Oncology
|
August 8, 2006
Preclinical and clinical development of novel agents that target the protein kinase C family
Maria Serova, Aïda Ghoul, Karim A Benhadji, et al.
Oral Oncology
|
November 7, 2017
Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data
Petr Szturz, Marie Budíková, Jan B Vermorken, et al.
Targeted Oncology
|
August 28, 2012
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies
Annemilaï Tijeras-Raballand, Cindy Neuzillet, Anne Couvelard, et al.
Head & Neck
|
March 8, 2013
Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma
Sébastien Albert, Maria Eugenia Riveiro, Caroline Halimi, et al.
European Journal of Medicinal Chemistry
|
May 20, 2014
Benzofuran derivatives as anticancer inhibitors of mTOR signaling
Christophe Salomé, Nigel Ribeiro, Thierry Chavagnan, et al.
Cancer Treatment Reviews
|
August 20, 2013
Unraveling galectin-1 as a novel therapeutic target for cancer
Lucile Astorgues-Xerri, Maria E Riveiro, Annemilaï Tijeras-Raballand, et al.
European Journal of Medicinal Chemistry
|
January 22, 2014
Benzofuran derivatives as a novel class of inhibitors of mTOR signaling
Christophe Salomé, Vanessa Narbonne, Nigel Ribeiro, et al.
Page
of 18